![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SL Wong, K Van Belle and RJ Sawchuk
Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Minneapolis.
The effect of probenecid (PBD) on the distributional transport of zidovudine (AZT) between plasma, cerebrospinal fluid (CSF) and brain extracellular fluid (ECF) was investigated by using microdialysis. New Zealand White rabbits received AZT, in a crossover design, during control and treatment periods. PBD was coadministered at one of two rates. One additional study involved a repeated control to investigate the possible existence of a period effect. In the low- and high-dose treatment groups, PBD decreased the total body clearance of AZT by 47.7 +/- 8.9 and 51.7 +/- 9.7%, respectively. PBD also decreased the clearance of AZT from CSF and thalamus ECF, prolonging the half-lives of AZT disappearance from the brain. Additionally, PBD elevated the AZT area under the concentration-time curve in the ventricular CSF 3- to 5- fold and the area under the thalamic ECF concentration-time curve by 5- to 6-fold, whereas the area under the plasma concentration-time curve increased only 2-fold. During PBD treatment the ratio area under the thalamic ECF concentration-time curve/area under the ventricular CSF concentration-time curve approached unity. These results provide evidence that AZT is actively transported outwardly across the CSF- and brain ECF-blood barriers, and this transport system is sensitive to PBD. A pharmacokinetic model that considers the effect of PBD on the AZT clearance from brain to plasma suggests that 73% of this pathway is subject to competitive inhibition by PBD.
This article has been cited by other articles:
|
|
 |
|
  S. C.S. Au-Yeung, K. W. Riggs, N. Gruber, and D. W. Rurak The Use of Microdialysis for the Study of Drug Kinetics: Central Nervous System Pharmacokinetics of Diphenhydramine in Fetal, Newborn, and Adult Sheep Drug Metab. Dispos., August 1, 2007; 35(8): 1285 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pan, N. Giri, and W. F. Elmquist Abcg2/Bcrp1 Mediates the Polarized Transport of Antiretroviral Nucleosides Abacavir and Zidovudine Drug Metab. Dispos., July 1, 2007; 35(7): 1165 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhuang, C. H. Fraga, K. E. Hubbard, N. Hagedorn, J. C. Panetta, C. M. Waters, and C. F. Stewart Topotecan Central Nervous System Penetration Is Altered by a Tyrosine Kinase Inhibitor Cancer Res., December 1, 2006; 66(23): 11305 - 11313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. S. Au-Yeung, D. W. Rurak, N. Gruber, and K. W. Riggs A PHARMACOKINETIC STUDY OF DIPHENHYDRAMINE TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER IN ADULT SHEEP: POTENTIAL INVOLVEMENT OF A CARRIER-MEDIATED MECHANISM Drug Metab. Dispos., June 1, 2006; 34(6): 955 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Marchand, A. Forsell, M. Chenel, E. Comets, I. Lamarche, and W. Couet Norfloxacin Blood-Brain Barrier Transport in Rats Is Not Affected by Probenecid Coadministration Antimicrob. Agents Chemother., January 1, 2006; 50(1): 371 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Marchand, C. Dahyot, I. Lamarche, E. Plan, O. Mimoz, and W. Couet Lack of Effect of Experimental Hypovolemia on Imipenem Muscle Distribution in Rats Assessed by Microdialysis Antimicrob. Agents Chemother., December 1, 2005; 49(12): 4974 - 4979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, J. D. Schuetz, W. F. Elmquist, and D. W. Miller Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 449 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Muller, A. dela Pena, and H. Derendorf Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1441 - 1453. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ohtsuki, T. Takizawa, H. Takanaga, N. Terasaki, T. Kitazawa, M. Sasaki, T. Abe, K.-i. Hosoya, and T. Terasaki In Vitro Study of the Functional Expression of Organic Anion Transporting Polypeptide 3 at Rat Choroid Plexus Epithelial Cells and Its Involvement in the Cerebrospinal Fluid-to-Blood Transport of Estrone-3-Sulfate Mol. Pharmacol., March 1, 2003; 63(3): 532 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lee, S. Dallas, M. Hong, and R. Bendayan Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations Pharmacol. Rev., December 1, 2001; 53(4): 569 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sun, P. M. Bungay, and W. F. Elmquist Effect of Capillary Efflux Transport Inhibition on the Determination of Probe Recovery During in Vivo Microdialysis in the Brain J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 991 - 1000. [Abstract] [Full Text]
|
|
|
|
|
|
M. Hong, L. Schlichter, and R. Bendayan A Novel Zidovudine Uptake System in Microglia J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 141 - 149. [Abstract] [Full Text]
|
|
|
|
|
|
S. Wada, M. Tsuda, T. Sekine, S. H. Cha, M. Kimura, Y. Kanai, and H. Endou Rat Multispecific Organic Anion Transporter 1 (rOAT1) Transports Zidovudine, Acyclovir, and Other Antiviral Nucleoside Analogs J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 844 - 849. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Gao, B. Stieger, B. Noé, J.-M. Fritschy, and P. J. Meier Localization of the Organic Anion Transporting Polypeptide 2 (Oatp2) in Capillary Endothelium and Choroid Plexus Epithelium of Rat Brain J. Histochem. Cytochem., October 1, 1999; 47(10): 1255 - 1264. [Abstract] [Full Text]
|
|
|
|
|
|
A. Kakee, T. Terasaki, and Y. Sugiyama Selective Brain to Blood Efflux Transport of para-Aminohippuric Acid across the Blood-Brain Barrier: In Vivo Evidence by Use of the Brain Efflux Index Method J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1018 - 1025. [Abstract] [Full Text]
|
|
|
|
|
|
K. Takasawa, T. Terasaki, H. Suzuki, T. Ooie, and Y. Sugiyama Distributed Model Analysis of 3'-Azido-3'-Deoxythymidine and 2',3'-Dideoxyinosine Distribution in Brain Tissue and Cerebrospinal Fluid J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1509 - 1517. [Abstract] [Full Text]
|
|
|
|
|
|
K. Takasawa, T. Terasaki, H. Suzuki, and Y. Sugiyama In Vivo Evidence for Carrier-Mediated Efflux Transport of 3'-Azido-3'-Deoxythymidine and 2',3'-Dideoxyinosine Across the Blood-Brain Barrier via a Probenecid-Sensitive Transport System J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 369 - 375. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Deguchi, K. Nozawa, S. Yamada, Y. Yokoyama, and R. Kimura Quantitative Evaluation of Brain Distribution and Blood-Brain Barrier Efflux Transport of Probenecid in Rats by Microdialysis: Possible Involvement of the Monocarboxylic Acid Transport System J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 551 - 560. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
